SMARCA4 and non-small cell lung carcinoma: The combination of the available published data in NSCLC for BRG1 mutations by Oike et al. and Rodriguez-Nieto et al. reveals that 1 of 28 (3.5%) NSCLC tumors had abrogating mutations in BRG1 [30, 31].